DK77884A - N-(omega-(1h-imidazol-1-yl)alkyl)arylamider - Google Patents

N-(omega-(1h-imidazol-1-yl)alkyl)arylamider Download PDF

Info

Publication number
DK77884A
DK77884A DK77884A DK77884A DK77884A DK 77884 A DK77884 A DK 77884A DK 77884 A DK77884 A DK 77884A DK 77884 A DK77884 A DK 77884A DK 77884 A DK77884 A DK 77884A
Authority
DK
Denmark
Prior art keywords
imidazol
omega
alkyl
aryl amides
amides
Prior art date
Application number
DK77884A
Other languages
Danish (da)
English (en)
Other versions
DK77884D0 (da
Inventor
Jr William Blythe Wright
Jeffery Bruce Press
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DK77884D0 publication Critical patent/DK77884D0/da
Publication of DK77884A publication Critical patent/DK77884A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
DK77884A 1983-02-28 1984-02-20 N-(omega-(1h-imidazol-1-yl)alkyl)arylamider DK77884A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47011283A 1983-02-28 1983-02-28

Publications (2)

Publication Number Publication Date
DK77884D0 DK77884D0 (da) 1984-02-20
DK77884A true DK77884A (da) 1984-08-29

Family

ID=23866324

Family Applications (1)

Application Number Title Priority Date Filing Date
DK77884A DK77884A (da) 1983-02-28 1984-02-20 N-(omega-(1h-imidazol-1-yl)alkyl)arylamider

Country Status (9)

Country Link
EP (1) EP0117462A3 (ko)
JP (1) JPS59164779A (ko)
KR (1) KR840007873A (ko)
AU (1) AU2507284A (ko)
DD (1) DD218890A5 (ko)
DE (1) DE3406416A1 (ko)
DK (1) DK77884A (ko)
GR (1) GR81797B (ko)
ZA (1) ZA841447B (ko)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655103A5 (de) * 1983-03-11 1986-03-27 Sandoz Ag Azolderivate, verfahren zu ihrer herstellung und ihre verwendung.
US4916145A (en) * 1987-07-10 1990-04-10 Hoffmann-La Roche Inc. Substituted n-[(pyridyl)alkyl]aryl-carboxamide
US5100909A (en) * 1988-07-25 1992-03-31 The Upjohn Company Acetylenic imidazoles having central nervous system activity
AU620894B2 (en) * 1988-07-25 1992-02-27 Upjohn Company, The Acetylenic imidazoles having central nervous system activity
US4962120A (en) * 1989-03-22 1990-10-09 Sterling Drug Inc. 1H-imidazole-1-acetamides
GB9127304D0 (en) * 1991-12-23 1992-02-19 Boots Co Plc Therapeutic agents
GB9312893D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
WO1995022327A1 (en) * 1994-02-22 1995-08-24 Knoll Ag Use of 1-(arylalkylaminoalkyl) imidazoles for treating neurological damage
DE19729640A1 (de) * 1996-08-17 1998-02-19 Ciba Geigy Ag Verfahren zur Herstellung von Nitrobenzamiden oder Aminobenzamiden
UA71587C2 (uk) 1998-11-10 2004-12-15 Шерінг Акцієнгезелльшафт Аміди антранілової кислоти та їхнє застосування як лікарських засобів
SE0002531D0 (sv) * 2000-07-05 2000-07-05 Active Biotech Ab Immune Enhancement
US7615565B2 (en) 2002-07-31 2009-11-10 Bayer Schering Pharma Aktiengesellschaft VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
WO2004056744A1 (en) * 2002-12-23 2004-07-08 Janssen Pharmaceutica N.V. Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
KR101099206B1 (ko) 2004-02-05 2011-12-27 프로비오드룩 아게 신규한 글루타미닐 시클라제 저해제
JP5014983B2 (ja) 2004-05-07 2012-08-29 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 11−ベータヒドロキシステロイドデヒドロゲナーゼ阻害剤としてのピロリジン−2−オン及びピペリジン−2−オン誘導体
UA87328C2 (en) 2004-08-30 2009-07-10 Янссен Фармацевтика Н.В. N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
DE602005017159D1 (de) 2004-08-30 2009-11-26 Janssen Pharmaceutica Nv Oxysteroid-dehydrogenase-inhibitoren
EP1786774B1 (en) 2004-08-30 2009-10-14 Janssen Pharmaceutica N.V. Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
EP1657241A1 (en) 2004-11-03 2006-05-17 Schering Aktiengesellschaft Novel anthranilamide pyridinureas as VEGF receptor kinase inhibitors
US7906533B2 (en) 2004-11-03 2011-03-15 Bayer Schering Pharma Ag Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
EP1655295A1 (en) 2004-11-03 2006-05-10 Schering Aktiengesellschaft Anthranilamide pyridinureas as VEGF receptor kinase inhibitors
EA200801591A1 (ru) * 2005-12-30 2008-12-30 Рэнбакси Лабораториз Лимитед Антагонисты мускаринового рецептора
EP2481408A3 (en) 2007-03-01 2013-01-09 Probiodrug AG New use of glutaminyl cyclase inhibitors
WO2014104272A1 (ja) 2012-12-28 2014-07-03 日本臓器製薬株式会社 ケイ皮酸アミド誘導体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3646057A (en) * 1969-04-06 1972-02-29 Hoffmann La Roche 2-nitroimidazoles
DE2854598A1 (de) * 1978-12-18 1980-07-03 Basf Ag N-substituierte carbonsaeureanilide, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide

Also Published As

Publication number Publication date
JPS59164779A (ja) 1984-09-17
AU2507284A (en) 1984-09-06
KR840007873A (ko) 1984-12-11
DD218890A5 (de) 1985-02-20
DE3406416A1 (de) 1984-08-30
GR81797B (ko) 1984-12-12
ZA841447B (en) 1984-10-31
EP0117462A3 (en) 1986-08-20
DK77884D0 (da) 1984-02-20
EP0117462A2 (en) 1984-09-05

Similar Documents

Publication Publication Date Title
DK77884A (da) N-(omega-(1h-imidazol-1-yl)alkyl)arylamider
NO832524L (no) N-(biocyklisk heterocyklyd)-4-piperidinaminer
DK1491A (da) Nitrogenholdige heterocycliske forbindelser
DK520584A (da) Oxazolidiner
DK416284D0 (da) Azolforbindelser
DE3468036D1 (de) N-substituted carbamoyl-lactam compound
DE3473442D1 (de) New alkyl diamine derivatives
DK119484A (da) Substituerede n-(omega-(1h-imidazol-1-yl)alkyl)amider
DK404084D0 (da) Pesticidt virksomme heterocycliske forbindelser
DK429884A (da) Heterocycliske forbindelser
IT1178771B (it) Stabilizzazione di polialchilenglicoli
DK329483D0 (da) Amidderivater
DK246584A (da) Heterocycliske forbindelser
NO840797L (no) Benzamidderivater
DK525884A (da) Heterocykliske forbindelser
DK96184D0 (da) Heterocycliske forbindelser
DK135483A (da) N-substituerede tetrahydrothiaziner
DK335684A (da) Azolforbindelser
DK2384D0 (da) Heterocycliske forbindelser
DK270583A (da) Benzo-annellerede heterocycliske forbindelser
DK344785D0 (da) N-thienyl-chloracet-amider
IT1169950B (it) Spoletta per proietti
DK554383D0 (da) Heterocycliske aminoforbindelser
DK557083A (da) Heterocykliske forbindelser

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment